Decreased alpha‐1,4‐linked
N
‐acetylglucosamine glycosylation in biliary tract cancer progression from biliary intraepithelial neoplasia to invasive adenocarcinoma
2020 ◽
Vol 111
(12)
◽
pp. 4629-4635
Motohiro Okumura
◽
Kazuhiro Yamanoi
◽
Takeshi Uehara
◽
Jun Nakayama
2020 ◽
Vol 231
(4)
◽
pp. e166
Naohiro Yoshida
◽
Nobuhisa Shirahama
◽
Takeshi Aoyagi
◽
Ayako Iwanaga
◽
Akihiro Saruwatari
◽
...
2014 ◽
Vol 466
(2)
◽
pp. 133-141
◽
Hanno Matthaei
◽
Philipp Lingohr
◽
Anke Strässer
◽
Dimo Dietrich
◽
Babak Rostamzadeh
◽
...
2002 ◽
Vol 29
(6U)
◽
pp. 51-53
◽
J Harder
◽
O Waiz
◽
M Geissler
◽
HE Blum
◽
A Schmitt-Gräff
◽
...
C Mayr
◽
A Wagner
◽
D Neureiter
◽
M Pichler
◽
M Ritter
◽
...
Orphan designation: (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-β-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one (etoposide toniribate), Treatment of biliary tract cancer
Piero Portincasa
◽
Leonilde Bonfrate
Close
Export Citation Format
Close
Share Document
Close